Opportunities in Global In Vitro Diagnostics Markets
Published January 2019 | 37 Pages | 9 Exhibits | Forecasts Through 2023
Order individually or subscribe and get a complete intel platform.
Overview
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Coverage in this report includes a detailed analysis of the current and forecast markets for invitro diagnostics technologies.
- Current Market Size & Forecast
- Competitive Landscape
- Supplier Revenues & Market Shares
- Current & Emerging Technologies
- Market Trends & Opportunities
- Plus More
Competitors Covered:
- Abbott Laboratories/Alere
- Arkray
- Becton Dickinson
- bioMerieux
- Bio-Rad Laboratories
- Carlyle Group
- Danaher/Cepheid
- DexCom
- DiaSorin
- Grifols SA
- Hologic
- Immucor
- Johnson & Johnson/Platinum Equity
- Myriad Genetics
- Panasonic Health
- Qiagen
- Roche Diagnostics
- Siemens
- Sysmex
- Thermo Fisher
- Werfen
- Others
Table of Contents
Executive Summary
Market by Clinical Application
Market by Geography
Suppliers
Markets by Technology
In Vitro Diagnostics
1.1 Market by Segment
1.2 Supplier Shares
1.3 Market by Geography
List of Exhibits
Summary Exhibit 1: Global MD&D Market by Major Technology Segment, 2018 and 2023
Summary Exhibit 2: MD&D Market by Major Clinical Application, 2018
Summary Exhibit 3: Geographic Distribution of Global MD&D Market, 2017-2023
Summary Exhibit 4: Distribution of Global MD&D Market, by Geography and Development Level, 2017-2023
Summary Exhibit 5: Estimated MD&D Sales of Major Suppliers, 2015-2018
Exhibit 1: Overview of Major Types of In Vitro Diagnostic Tests
Exhibit 2: In Vitro Diagnostics, Global Market by Major Segment, 2017-2023
Exhibit 3: Global Molecular Diagnostics Market, Supplier Shares, 2018
Exhibit 4: Global IVD Market, Supplier Shares, 2018
Ready to get started?
We help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
